These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17199162)

  • 1. [Submacular hemorrhage following photodynamic therapy in the treatment of choroidal neovascularization].
    Díaz-de-Durana-Santa-Coloma E; Fernández-Ares ML; Iturralde-Errea D; Salazar-Díez JL; Vázquez-Cruchaga E; López-Garrido JA
    Arch Soc Esp Oftalmol; 2006 Dec; 81(12):685-91. PubMed ID: 17199162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy for choroidal neovascularization associated with submacular hemorrhage in age-related macular degeneration.
    Bakri SJ; Nickel J; Yoganathan P; Beer PM
    Ophthalmic Surg Lasers Imaging; 2006; 37(4):278-83. PubMed ID: 16898387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large submacular hemorrhage following PDT with verteporfin in patients with occult CNVM secondary to age-related macular degeneration.
    Chaudhry NA; Lavaque AJ; Tom DE; Liggett PE
    Ophthalmic Surg Lasers Imaging; 2007; 38(1):64-8. PubMed ID: 17278540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subfoveal hemorrhage after verteporfin photodynamic therapy in treatment of choroidal neovascularization.
    Gelisken F; Inhoffen W; Karim-Zoda K; Grisanti S; Partsch M; Voelker M; Bartz-Schmidt KU
    Graefes Arch Clin Exp Ophthalmol; 2005 Mar; 243(3):198-203. PubMed ID: 15258778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.
    Verteporfin In Photodynamic Therapy Study Group
    Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large submacular hemorrhages after verteporfin therapy.
    Do DV; Bressler NM; Bressler SB
    Am J Ophthalmol; 2004 Mar; 137(3):558-60. PubMed ID: 15013883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.
    Schmidt-Erfurth U; Miller JW; Sickenberg M; Laqua H; Barbazetto I; Gragoudas ES; Zografos L; Piguet B; Pournaras CJ; Donati G; Lane AM; Birngruber R; van den Berg H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
    Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choroidal ischemia after photodynamic therapy with verteporfin for choroidal neovascularization.
    Isola V; Pece A; Parodi MB
    Am J Ophthalmol; 2006 Oct; 142(4):680-3. PubMed ID: 17011867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Massive hemorrhage following photodynamic therapy in exudative ARMD].
    Hartmann L; Adenis JP; Robert PY
    J Fr Ophtalmol; 2008 Sep; 31(7):714.e1-7. PubMed ID: 18971847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal hemorrhage after photodynamic therapy in patients with subfoveal choroidal neovascularization caused by age-related macular degeneration.
    Theodossiadis GP; Panagiotidis D; Georgalas IG; Moschos M; Theodossiadis PG
    Graefes Arch Clin Exp Ophthalmol; 2003 Jan; 241(1):13-8. PubMed ID: 12545287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy with verteporfin following transpupillary thermotherapy for CNV evolving from an initially occult to a predominantly classic form, in patients with AMD.
    Hamon F; Goeminne P
    Semin Ophthalmol; 2001 Dec; 16(4):223-32. PubMed ID: 15513445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.
    Bressler NM; Arnold J; Benchaboune M; Blumenkranz MS; Fish GE; Gragoudas ES; Lewis H; Schmidt-Erfurth U; Slakter JS; Bressler SB; Manos K; Hao Y; Hayes L; Koester J; Reaves A; Strong HA;
    Arch Ophthalmol; 2002 Nov; 120(11):1443-54. PubMed ID: 12427056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy.
    Moshfeghi DM; Kaiser PK; Grossniklaus HE; Sternberg P; Sears JE; Johnson MW; Ratliff N; Branco A; Blumenkranz MS; Lewis H
    Am J Ophthalmol; 2003 Mar; 135(3):343-50. PubMed ID: 12614752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
    Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
    Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula.
    Lee SC; Seong YS; Kim SS; Koh HJ; Kwon OW
    Ophthalmologica; 2004; 218(3):193-201. PubMed ID: 15103216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1.
    Blinder KJ; Bradley S; Bressler NM; Bressler SB; Donati G; Hao Y; Ma C; Menchini U; Miller J; Potter MJ; Pournaras C; Reaves A; Rosenfeld PJ; Strong HA; Stur M; Su XY; Virgili G; ;
    Am J Ophthalmol; 2003 Sep; 136(3):407-18. PubMed ID: 12967792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.
    Lazic R; Gabric N
    Ophthalmology; 2007 Jun; 114(6):1179-85. PubMed ID: 17544776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy in practice: a review of the results of the first 12 months experience with verteporfin at the Royal Victorian Eye and Ear Hospital.
    Essex RW; Qureshi SH; Cain MS; Harper CA; Guymer RH
    Clin Exp Ophthalmol; 2003 Dec; 31(6):476-81. PubMed ID: 14641153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).
    Costa RA; Jorge R; Calucci D; Melo LA; Cardillo JA; Scott IU
    Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1273-80. PubMed ID: 17333238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.